Medicare Enrolled

Dr. Marc Gutin, MD

Endocrinology · San Dimas, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
615 E FOOTHILL BLVD STE C, San Dimas, CA 91773
6263358094
In practice since 2006 (19 years)
NPI: 1861423709 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gutin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gutin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gutin

Dr. Marc Gutin is an endocrinology specialist in San Dimas, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gutin performed 2,225 Medicare services across 964 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gutin received a total of $46,447 from 61 pharmaceutical and/or device companies across 1196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gutin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 28% volume in CA $46,447 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,225
Medicare services
Top 28% in CA for endocrinology
964
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
789 $72 $200
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
723 $3 $10
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
351 $28 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
192 $79 $295
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
115 $10 $35
New patient office visit, complex (60-74 min) 36 $177 $555
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
19 $131 $455
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$46,447
Total received (2018-2024)
Avg $6,635/year across 7 years
Top 8% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,196
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,740 (51.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,971 (45.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,736 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,527
2023
$4,074
2022
$3,341
2021
$6,489
2020
$9,060
2019
$9,476
2018
$10,481

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mannkind Corporation
$589
Lilly USA, LLC
$561
Abbott Laboratories
$345
Amgen Inc.
$289
Dexcom, Inc.
$250
Novo Nordisk Inc
$172
Xeris Pharmaceuticals, Inc.
$158
Corcept Therapeutics
$152
Madrigal Pharmaceuticals
$131
ABBVIE INC.
$121
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
SANOFI-AVENTIS U.S. LLC
$83
Ascensia Diabetes Care Us Inc.
$75
Esperion Therapeutics, Inc.
$61
RECORDATI_RARE_DISEASES_INC.
$61
Antares Pharma, Inc.
$50
Insulet Corporation
$48
Lexicon Pharmaceuticals, Inc.
$48
CeQur Corporation
$44
AstraZeneca Pharmaceuticals LP
$43
Radius Health, Inc.
$39
BETA BIONICS, INC.
$29
Tandem Diabetes Care, Inc.
$29
Embecta Corp.
$22
Ascendis Pharma Inc
$19
GlaxoSmithKline, LLC.
$15
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,942
Lilly USA, LLC
$7,385
Novo Nordisk Inc
$3,106
Amgen Inc.
$2,302
AstraZeneca Pharmaceuticals LP
$2,190
Dexcom, Inc.
$1,637
Mannkind Corporation
$1,586
Abbott Laboratories
$1,382
Tandem Diabetes Care, Inc.
$1,206
SANOFI-AVENTIS U.S. LLC
$1,076
MannKind Corporation
$532
Medtronic, Inc.
$398
Antares Pharma, Inc.
$390
Horizon Therapeutics plc
$379
Insulet Corporation
$377
Esperion Therapeutics, Inc.
$372
Radius Health, Inc.
$321
Embecta Corp.
$318
Xeris Pharmaceuticals, Inc.
$316
Amarin Pharma Inc.
$297
ABBVIE INC.
$238
Novartis Pharmaceuticals Corporation
$212
Bayer Healthcare Pharmaceuticals Inc.
$211
Janssen Pharmaceuticals, Inc
$198
Bigfoot Biomedical Inc
$182
Janssen Scientific Affairs, LLC
$154
Corcept Therapeutics
$152
Madrigal Pharmaceuticals
$131
RECORDATI_RARE_DISEASES_INC.
$107
Merck Sharp & Dohme Corporation
$105
Becton, Dickinson and Company
$97
Bayer HealthCare Pharmaceuticals Inc.
$93
DEXCOM, INC.
$83
Ascensia Diabetes Care Us Inc.
$75
Supernus Pharmaceuticals, Inc.
$75
Lexicon Pharmaceuticals, Inc.
$72
CeQur Corporation
$65
Senseonics, Incorporated
$62
IBSA Pharma Inc.
$61
AbbVie Inc.
$51
Regeneron Healthcare Solutions, Inc.
$47
Medtronic MiniMed, Inc.
$41
Aegerion Pharmaceuticals, Inc.
$40
Kowa Pharmaceuticals America, Inc.
$40
AbbVie, Inc.
$38
BETA BIONICS, INC.
$29
Currax Pharmaceuticals LLC
$26
Companion Medical, Inc.
$26
Acella Pharmaceuticals, LLC
$25
GRT US Holding, Inc.
$25
Ascendis Pharma Inc
$19
Aytu BioScience, Inc
$18
LifeScan, Inc.
$18
Acerus Pharmaceuticals Corporation
$18
Ascensia Diabetes Care US Inc.
$17
Endo Pharmaceuticals Inc.
$16
Vertiflex, Inc.
$16
GlaxoSmithKline, LLC.
$15
Tolmar, Inc.
$15
Shire North American Group Inc
$14
Zealand Pharma US, Inc.
$12
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CONTRAVE · CeQur Simplicity · Corlanor · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · Inpefa · JANUVIA · JARDIANCE · JATENZO · JUXTAPID · Kerendia · Korlym · LEQVIO · LINZESS · LYUMJEV · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · OT Verio Flex Starter Kit · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · Qutenza · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SYNTHROID · Saxenda · Superion ISS · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TZIELD · Tirosint · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XIAFLEX · XYOSTED · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for endocrinology in CA.

Looking for an endocrinology specialist in San Dimas?
Compare endocrinologists in the San Dimas area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
108
Per 100K population
1.1
County median income
$87,760
Nearest hospital
SAN DIMAS COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gutin is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with speaking/promotional industry engagement in the top 8% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gutin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gutin performed 789 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gutin receive payments from pharmaceutical companies?
Yes. Dr. Gutin received a total of $46,447 from 61 companies across 1,196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gutin's costs compare to other endocrinologists in San Dimas?
Dr. Gutin's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gutin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →